Manasvi Gupta
New York, NYNPI 1780249813
Payments from drug & device makers
$24,213in general payments, 2019–2025
Across 227 payments — averaging $106.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Boston Scientific$4K
- Biotronik Inc.$4K
- Abbott$2K
- Medical Device Business Services, Inc.$2K
- Biosense Webster, Inc.$323
- plus $275 from 4 others
What the payments were for
- Travel & lodging$14,76161%
- Food & beverage$9,09338%
- Education$3601%
General payments by program year
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 129 | $11,374 |
| Boston Scientific | 25 | $4,138 |
| Biotronik Inc. | 27 | $4,035 |
| Abbott | 24 | $2,434 |
| Medical Device Business Services, Inc. | 8 | $1,633 |
| Biosense Webster, Inc. | 10 | $323 |
| Amgen | 1 | $116 |
| E.r. Squibb & Sons, L.L.C. | 1 | $93 |
| Abiomed | 1 | $48 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCOLADE SR$2,280
- ENSITE$1,532
- Carto 3$1,391
- EMBLEM MRI S-ICD$994
- Micra$896
- Repatha$116
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Candesartan Cilexetil | 13 | $426 |
| Spironolactone | 13 | $17 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.